Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001080098 | SCV000282902 | likely benign | Ataxia-telangiectasia syndrome | 2023-10-19 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000587579 | SCV000512145 | likely benign | not provided | 2019-10-15 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000579933 | SCV000682059 | likely benign | Hereditary cancer-predisposing syndrome | 2017-06-14 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000587579 | SCV000694224 | uncertain significance | not provided | 2016-02-16 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000579933 | SCV002532200 | uncertain significance | Hereditary cancer-predisposing syndrome | 2021-05-17 | criteria provided, single submitter | curation | |
ARUP Laboratories, |
RCV000587579 | SCV004565150 | likely benign | not provided | 2023-08-30 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV004591050 | SCV005084662 | benign | Familial cancer of breast | 2024-05-09 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is intronic and is not expected to impact mRNA splicing. This variant is strongly associated with less severe personal and family histories of cancer, typical for individuals without pathogenic variants in this gene [PMID: 25085752]. |
Department of Pathology and Laboratory Medicine, |
RCV001354655 | SCV001549321 | uncertain significance | Malignant tumor of breast | no assertion criteria provided | clinical testing | The ATM c.2467-7C>T variant was not identified in the literature nor was it identified in the COGR, Cosmic, LOVD 3.0, or the ATM-LOVD database. The variant was identified in dbSNP (ID: rs768850329) as "With Uncertain significance allele", and in ClinVar (classified as likely benign by Invitae, GeneDx, Color Genomics; as uncertain significance by Integrated Genetics/Laboratory Corporation of America). The variant was identified in control databases in 5 of 245888 chromosomes at a frequency of 0.00002 (Genome Aggregation Database Feb 27, 2017). The variant was observed in the following populations: European Non-Finnish in 3 of 111516 chromosomes (freq: 0.00003), and Ashkenazi Jewish in 2 of 9834 chromosomes (freq: 0.0002); it was not observed in the African, Other, Latino, East Asian, Finnish, and South Asian populations. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) do not predict a difference in splicing. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as a variant of uncertain significance. | |
Genome Diagnostics Laboratory, |
RCV000587579 | SCV001808739 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000587579 | SCV001953737 | likely benign | not provided | no assertion criteria provided | clinical testing |